Interim Management Statement

RNS Number : 2337G

Dechra Pharmaceuticals PLC

10 May 2011

 



Issued by Citigate Dewe Rogerson Ltd, Birmingham

Date: Tuesday, 10 May 2011

Dechra^® Pharmaceuticals PLC

Interim Management Statement

Dechra Pharmaceuticals PLC ("Dechra" or the "Group"), publishes its Interim Management Statement covering the period from 1 January 2011 to the date of this announcement.

Overall trading in the third quarter of the current financial year was in line with our expectations and remained consistent with the level seen in the first half of the financial year.  Group revenue for the three months ended 31 March 2011 was 4.1% ahead of last year.  For the nine months ended 31 March 2011, Group revenue increased by 4.0% over the corresponding period in the prior year.

In the third quarter, our European products business revenue grew by 5.1% compared to the same period last year.  For the nine months to 31 March 2011 revenue was ahead of the comparable period by 5.5%.  Pharmaceuticals revenue was in line with expectations but diets revenue, whilst still outperforming the market, has experienced some softness.

Revenue from US Pharmaceuticals was ahead of last year by 68.1% in the third quarter and by 36.4% for the nine months ended 31 March 2011.  The third quarter growth includes the benefit of the DermaPet acquisition completed in October 2010.

The Services division increased revenues in the third quarter by 2.6% whilst revenue for the nine months ended 31 March 2011 was 2.9% ahead of the equivalent period last year.

Other than as noted above, there have been no material events or transactions between 1 January 2011 and the date of this announcement.

Current trading remains in line with the Board's expectations and we remain confident that the Group will continue to make good strategic progress throughout the remainder of the financial year.

Enquiries:
Ian Page, Chief Executive	Fiona Tooley, Director
Simon Evans, Group Finance Director	Keith Gabriel, Senior Account Manager
Dechra Pharmaceuticals PLC	Citigate Dewe Rogerson
Tel: [phone]	Tel: [phone]
Mobile: [phone] (IP) Mobile: [phone] (SE)	Mobile: [phone] (FMT) Mobile: [phone] (KG)
www.dechra.com
[e-mail]

Trademarks appear throughout this release in italics.  Dechra and the Dechra 'D' logo are registered Trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

IMSLLFVEEDIAIIL